Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An update from Reviva Pharmaceuticals Holdings ( (RVPH) ) is now available.
On February 13, 2025, Reviva Pharmaceuticals Holdings’ Compensation Committee approved several compensation arrangements for its executives, with retroactive base salary increases effective from January 1, 2025. Additionally, the committee set new bonus targets for 2025 and approved significant stock option grants, reflecting confidence in the leadership team and aligning their interests with shareholders.
More about Reviva Pharmaceuticals Holdings
Reviva Pharmaceuticals Holdings, Inc. operates in the pharmaceutical industry, focusing on developing and commercializing therapies for unmet medical needs, particularly in the central nervous system and respiratory sectors.
YTD Price Performance: -10.45%
Average Trading Volume: 3,018,118
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $83.84M
For an in-depth examination of RVPH stock, go to TipRanks’ Stock Analysis page.
